Contractile responses of vascular smooth muscle strips (rabbit aorta) to angiotensin, vasopressin and serotonin are potentiated by amounts of metanephrine, ephedrine or tyramine that produce no contractions by themselves. Epinephrine and norepinephrine contractions of aortic strips are not potentiated. Phentolamine and bretylium prevent this potentiating effect of metanephrine and ephedrine; the effect of tyramine is blocked by bretylium but only partially by high doses of phentolamine. Contractions of strips pretreated with reserpine are not potentiated except when repleted with norepinephrine. It is suggested as a working hypothesis that low doses of metanephrine release storage norepinephrine which acts on the contractile machinery to potentiate its response to other stimulating agents.
• Metanephrine [2-(2-methoxy, 3-hydroxyphenyl) -2-hydroxy-N-methyl ethylamine] is a normal metabolite of epinephrine produced by the action of catechol-O-methyl transferase. It is further metabolized slowly to 3-methoxy-4-hydroxy mandelic acid by monoamine oxidase. 1 Although the metabolic pathway of catecholamines has been extensively studied, 2 the pharmacology of metanephrine has received less attention. Bacq and Renson 3 showed that metanephrine is 400 to 600 times less active than norepinephrine on blood pressure of cats and 40 to 100 times less active than epinephrine, and that it sensitized the nictitating membrane in cats to epinephrine, to norepinephrine and to pre-or postganglionic electrical stimulation. This sensitization was peripheral and could be abolished by dibenzyline. They postulated that metanephrine may regulate the sensitivity of a-adrenergic receptors. Dejardin 4 has shown that meta-From the Research Division, Cleveland Clinic Foundation, Cleveland, Ohio.
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Accepted for publication June 10, 1966. nephrine blocks the inhibitory action of catecholamines on isolated tracheal muscle of guinea pigs. Chrusciel et al. 8 have shown that it blocks the chronotropic and inotropic actions of catecholamines on isolated perfused rat heart. Both groups suggest that metanephrine decreases the sensitivity of /3-adrenergic receptors.
Most of the action of ephedrine and tyramine on vascular smooth muscle is due to release of norepinephrine from storage sites. 6 Depleting stores with reserpine abolished responses to tyramine and greatly decreased the response to ephedrine.
Methods
Isolated rabbit aortic strips were prepared according to the method of Furchgott and Bhadrakom. 7 Animals were killed by decapitation or air embolism, the aortas were removed within 5 min, washed in ice-cold Krebs' solution, and spirally cut free-hand at an angle of about 30°. Each 1.5 to 2.0-mm wide strip was mounted in a 25-ml muscle bath in Krebs' solution (6.9 g of NaCl, 2.1 g of NaHCO s , 0.35 g of KC1, 0.28 g of CaCl 2 , 0.11 g of MgCl 2 , 0.14 g of Na 2 HPO 4 , and 2.0 g of glucose per liter) at 37° and aerated with 95* O 2 and 5% CO 2 . The isotonic lever exerted a tension on each strip of 0.6 g. The aortas were allowed to equilibrate for 2 hours 539 during which time they relaxed, occasionally almost doubling initial length. The few strips that did not relax were discarded. Cat carotid arteries were also used but since they developed rapid tachyphylaxis to angiotensin, 8 they were used only for studies with serotonin. Cats were anesthetized with 30 mg/kg of Na pentobarbital ip before removal of arteries.
Stimulating agents, dissolved in Krebs' solution, were kept in contact with the strip for 3 min. The strips were then washed repeatedly, and allowed to recover for 12 min. When potentiating or blocking agents were used, they were added to the muscle bath, followed 3 min later by the stimulating agent. After another 3 min the strip was washed, and allowed to recover.
All results were expressed in percent of maximal contraction which occurred with 100 ng per ml of angiotensin amide, 100 ng per ml of serotonin creatinine sulfate, 100 ng per ml of epinephrine, and 80 ng per ml of norepinephrine. Maximal contraction consisted of shortening by 25 to 30% of resting length. Assuming a free-hand spiral cut of about 30°, the circular smooth muscle fibers now placed 30° from the vertical must have been contracting 50 to 6O5J of their resting length, which is maximal contraction for most muscles. The data are averages of 5 trials on each strip and repeated on at least 4 different strips. Results were expressed as the arithmetic mean. Standard error (SE) was also expressed in percent of maximal contraction, and was never greater than ± 2.OX.
Rabbits were given 2.5 mg per kg of reserpine 48 hours prior to use, followed by 5.0 mg per kg of reserpine 24 hours later to deplete catecholamines from arterial tissue. The strips, mounted in the usual fashion, relaxed quickly during equilibration. To replenish the stores, 0.4 fjLg per ml of norepinephrine was added to the bath for 30 min, washed out and the treatment repeated twice.
The drugs used and their sources were as follows: synthetic asparagine 1 -valine 5 -angiotensin (Ciba); synthetic bradykinin (Sandoz); synthetic arginine 8 -vasopressin (Sandoz); metanephrine HC1 (Calbiochem); norepinephrine bitartrate (Levophed, Winthrop); epinephrine chloride (Parke Davis); ephedrine sulfate (Lilly); tyramine HC1 (Eastman Organic Chemicals); serotonin creatinine sulfate (Regis Chemicals); phentolamine methanesulfonate (Regitine, Ciba); reserpine (Serpasil, Ciba); phenoxybenzamine HC1 (Dibenzyline, Smith, Kline & French); bretylium tosyiate (Wellcome); a-methyl-DOPA (Aldomet, Merck, Sharp and Dohme); and dichloroisoproterenol (DCI, Lilly).
All drug concentrations were expressed as free base except serotonin, which was expressed as a salt of creatinine sulfate. The peptides were weighed and kept as a stock solution of 1 mg per ml in 0.1 N acetic acid. Metanephrine potentiation of contractile responses to vasopressin.
Results

Metanephrine
the contractile response of rabbit aorta to angiotensin (8 ng per ml) and cat carotid and rabbit aorta to serotonin (20 ng per ml) ( Fig. 1 ). Cat carotid arteries developed rapid tachyphylaxis to angiotensin, 8 (Table 2 ). Doses larger than 1.0 ng per ml contracted muscle directly.
Aortic strips depleted of catecholamines by previous administration of reserpine to rabbits responded to all stimulating agents used with an increase in sensitivity. There was, however, no potentiation by metanephrine. After potentiating effect of metanephrine was immediately restored ( Table 3 and Fig. 3 ).
Discussion
Bacq and Renson 8 showed that metanephrine potentiated the contractile response of CircnUticn Ruttrcb, Vol. XIX, Stpitmbtr 1966 nictitating membrane smooth muscle to norepinephrine and epinephrine. Our results differ, in that while metanephrine potentiates angiotensin, vasopressin and serotonin, the response of vascular smooth muscle to norepinephrine and epinephrine is unaffected. The potentiation occurs with an amount of metanephrine that by itself will not contract; it can be blocked with phentolamine and bretylium. Reserpinized blood vessels showed no potentiation but when incubated with norepinephrine, the potentiating effect returned in full. Thus metanephrine, like tyramine and ephedrine, might be classified as an indirectly acting amine whose action is mediated by norepinephrine.
It is generally assumed that agents that act on the outside of cell membranes, have specific receptor sites. These sites for angiotensin and vasopressin differ from the a-and /3adrenergic receptors and from each other as shown by the lack of cross tachyphylaxis in isolated strips; 8 serotonin sites may have similarities to catecholamine sites, since both are inhibited by certain a-adrenergic blocking agents. 0 Since metanephrine potentiates three unrelated myotropic agents that probably have different receptor sites, it may be changing the contractile machinery in the cell, causing myotropic agents, other than catecholamines, to be potentiated. We propose the following highly speculative scheme, applicable to vascular smooth muscle. Metanephrine first binds to a-adrenergic receptors, as shown by the blocking effect of phentolamine. Dibenzyline only partially blocks because of its slow onset of action. More than 3 min are required to form its reactive intermediates. Since the side chains of epinephrine and metanephrine are the same, it is possible that they bind to the same receptor. The catechol ring of metanephrine has an extra methyl group, and so the binding will probably not be as firm as epinephrine, so that epinephrine can displace metanephrine. 10 Once metanephrine binds to the a-adrenergic receptor site, it releases norepinephrine from storage sites, as shown by Burn and Rand 6 to be true for tyramine and ephedrine. These storage sites have been shown to be inside the cell membrane in nerve endings and adrenal medulla 11 and could possibly be there in vascular smooth muscle. Released norepinephrine interacts either directly or indirectly with actomyosin strands, facilitating their contraction, possibly by a mechanism similar to that described by Stam and Honig or Feinberg and Alma. When another stimulus such as angiotensin reaches the muscle, it binds to its own receptor site, but now produces maximal contraction. This release of storage norepinephrine possibly occurs intracellularly, close to the contractile machinery. Large doses of metanephrine release large amounts of norepinephrine. Some of this spills over extracellularly, stimulating the muscle to contract. The same speculation may apply for ephedrine and tyramine. When amounts small enough not to produce a response by themselves are presented to a muscle strip, they release norepinephrine, which facilitates the contractile machinery.
This theory explains why epinephrine and norepinephrine are not potentiated by metanephrine. Since both of them must interact with an a-adrenergic receptor before producing their own response, they can only do so by displacing metanephrine and thus preventing the release of storage norepinephrine. Phentolamine, by binding very strongly to the a-adrenergic receptors, displaces metanephrine, preventing the release of storage norepinephrine, and thus reversing the potentiation.
According to our theory, ephedrine acts like CirciUtion Rts-rcb, Vol. XIX, StpHmitr 1966 metanephrine, binding to a-adrenergic receptors, releasing storage norepinephrine, and potentiating contractile responses to stimulating agents. Tyramine, on the other hand, although also releasing storage norepinephrine, is probably bound to a site different from the a-adrenergic receptors, because large doses of phentolamine are necessary to block its effect. However, tyramine potentiates angiotensin, vasopressin and serotonin by a similar mechanism.
The evidence indicating that the intracellular substance mediating the potentiating effect of metanephrine is storage norepinephrine, is the observations that bretylium tosylate inhibits this effect, and the studies on reserpinized blood vessel strips. Bretylium decreases the amount of norepinephrine released per stimulus, finally blocking release completely. 14 Reserpine depletes catecholamine stores, which can be replenished by addition of norepinephrine to the muscle bath. Replenishing the tissue with norepinephrine restores the potentiating effect of metanephrine and tyramine.
The increased responsiveness seen in reserpinized strips could be due to saturation of the contractile machinery by norepinephrine released from storage sites. Most of this released norepinephrine is removed from the tissue, but a small amount still remains 16 and is not taken up by storage granules. Thus free intracellular norepinephrine is increased, leading to a potentiated response.
